Connacht Asset Management’s Inhibrx, Inc. Common Stock INBX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-9,173
| Closed | -$238K | – | 104 |
|
|
2023
Q2 | $238K | Sell |
9,173
-2,260
| -20% | -$58.7K | 0.33% | 57 |
|
|
2023
Q1 | $216K | Sell |
11,433
-710
| -6% | -$13.4K | 0.09% | 72 |
|
|
2022
Q4 | $299K | Sell |
12,143
-809
| -6% | -$19.9K | 0.14% | 64 |
|
|
2022
Q3 | $232K | Sell |
12,952
-1,555
| -11% | -$27.9K | 0.16% | 72 |
|
|
2022
Q2 | $165K | Buy |
14,507
+2,146
| +17% | +$24.4K | 0.07% | 93 |
|
|
2022
Q1 | $275K | Buy |
12,361
+5,266
| +74% | +$117K | 0.14% | 76 |
|
|
2021
Q4 | $310K | Buy |
+7,095
| New | +$310K | 0.3% | 83 |
|